logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Petros Grivas

Fred Hutchinson Cancer Center
H指数:61
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating Tumor Cell Synaptophysin and Androgen Receptor Expression Reflect Prostate Cancer Phenotypes in Metastatic Disease

循环肿瘤细胞突触素和雄激素受体表达反映转移性前列腺癌的表型

Prostate
IF2.5
2026-10-120
OAAI
Ethan Lo; Alisa Clein; Michael Tam; Sara Trimble; Michael Hardin; Arturo Ramirez; Eric Kaldjian; Evan Y. Yu; Heather H. Cheng; Todd A. Yezefski; Andrew C. Hsieh; Petros Grivas; Bruce Montgomery; Peter S. Nelson; Michael T. Schweizer; Daniel E. Sabath; Steven Blinka
Prevalence of PD-L1-High Tumor Expression and Association with First-Line Treatment Outcomes in Patients with Metastatic Urothelial Carcinoma: Results from a Prospective Observational Cohort Study

PD-L1高表达肿瘤的患病率及其与转移性尿路上皮癌患者一线治疗效果的关联：一项前瞻性观察队列研究的结果

Targeted Oncology
IF4
2026-10-020
OAAI
Petros Grivas; Piyush K. Agarwal; Hikmat Al-Ahmadie; Terence Friedlander; Daniel M. Geynisman; Yair Lotan; Alicia K. Morgans; Fernando J. Bianco; Sreenivasa Chandana; Bruno Fang; Michael Large; Joshua J. Meeks
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes

致死性转移性膀胱癌亚型的演化和异质性

Nature
IF48.5
2026-09-160
OAAI
Pushpa Itagi; Samantha L. Schuster; Sonali Arora; Thomas W. Persse; Jennifer A. Waters; Michael Yang; Alan Min; Pooja Chandra; Mohamed Adil; Patricia C. Galipeau; Dmytro Rudoy; Allie S. Kreitman; Yixin Lin; Minjeong Ko; Erolcan Sayar; Robert D. Patton; Lori Kollath; Abby Meis; Samuel Lindergren; Nathan Ji; Khursheed Ali; Hrishi Venkatesh; Cynthia L. Wladyka; A. Patrick McDeed; Claire B. Mills; Manasvita Vashisth; Jin Yeong Kim; Rosa Nadal; Jessica E. Hawley; Todd A. Yezefski; Sarah P. Psutka; John L. Gore; Daniel W. Lin; Peter S. Nelson; Heather H. Cheng; Michael T. Schweizer; Lawrence Fong; John K. Lee; Evan Y. Yu; Eva Corey; Colm Morrissey; Petros Grivas; Robert B. Montgomery; Jonathan L. Wright; Michael C. Haffner; Funda Vakar-Lopez; Omar Y. Mian; Hung-Ming Lam; Andrew C. Hsieh; Gavin Ha
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识

CA: A Cancer Journal for Clinicians
IF0
2025-12-130
OAAI
Rana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study

在恩沃利单抗之后的尿路上皮癌患者中，萨cituzumab govitecan的疗效：UNITE研究的分析

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
2025-12-010
OAAI
Jindal, Tanya; Jiang, Cindy Y.; Alhalabi, Omar; Davidsohn, Matthew; Freeman, Dory; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Nizam, Amanda; Nguyen, Charles B.; Oh, Eugene; Tsung, Irene; Glover, Michael J.; Khaki, Ali Raza; Taylor, Amy K.; Jaime-Casas, Salvador; Jang, Albert; Lemke, Emily; Pywell, Cameron; Evans, Sean T.; Shin, Denny; Bilen, Mehmet A.; Basu, Arnab; Kilari, Deepak; Tripathi, Abhishek; Brown, Jason; Emamekhoo, Hamid; Davis, Nancy B.; Shah, Sumit; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Alva, Ajjai; Campbell, Matthew T.; Koshkin, Vadim S.
Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome Interpretation

解决EV-302 III期随机临床试验化疗组治疗中断率不均衡的问题：对结局解释的影响

Clinical Genitourinary Cancer
IF2.7
2025-12-010
PRE
Robesti, Daniele; Micheli, Filippo; Rai, Shesh N.; Fallara, Giuseppe; Gallina, Andrea; Montorsi, Francesco; Briganti, Alberto; Fossati, Nicola; Grivas, Petros; van der Heijden, Antoine G.; Ploussard, Guillaume; Malavaud, Bernard; Martini, Alberto
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study

膀胱癌亚型组织学患者中经尿道膀胱肿瘤切除术与根治性膀胱切除术病理结果的一致性：一项回顾性队列研究

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
2025-11-010
PRE
Bakaloudi, Dimitra Rafailia; Koehne, Elizabeth L.; Voutsinas, Jenna M.; Diamantopoulos, Leonidas N.; Makrakis, Dimitrios; Grivas, Petros; True, Lawrence D.; Tretiakova, Maria S.; Vakar-Lopez, Funda; Psutka, Sarah P.; Holt, Sarah K.; Gore, John L.; Lin, Daniel W.; Schade, George R.; Nyame, Yaw A.; Hsieh, Andrew C.; Yezefski, Todd; Hawley, Jessica E.; Schweizer, Michael T.; Cheng, Heather H.; Yu, Evan Y.; Montgomery, R. Bruce; Wu, Qian; Wright, Jonathan L.
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study

FGFR3突变型晚期尿路上皮癌中，erdafitinib在enfortumab vedotin治疗前或治疗后的疗效：UNITE协作研究的分析

ONCOLOGIST
IF4.2
2025-11-010
PRE
Jiang, Cindy Y.; Hwang, Hyunsoo; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Taylor, Amy K.; Nizam, Amanda; Jindal, Tanya; Glover, Michael J.; Khaki, Ali Raza; Barata, Pedro C.; Nguyen, Charles B.; Oh, Eugene; Davis, Nancy B.; Mabey, Hannah; Hoimes, Christopher J.; Evans, Sean T.; Abuqayas, Bashar; Lemke, Emily; Tsung, Irene; Qiao, Wei; Kilari, Deepak; Zakharia, Yousef; Bilen, Mehmet A.; Milowsky, Matthew, I; Shah, Sumit A.; Gupta, Shilpa; Emamekhoo, Hamid; Bellmunt, Joaquim; Alva, Ajjai S.; Grivas, Petros; Msaouel, Pavlos; Koshkin, Vadim S.; Campbell, Matthew T.; Alhalabi, Omar
A plain language summary of the TROPiCS-04 study: sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tract

TROPiCS-04研究的通俗语言摘要：沙西妥珠单抗在铂类化疗和免疫疗法之后，用于患有膀胱、尿道或上尿路局部晚期或转移性癌症的人群

FUTURE ONCOLOGY
IF2.6
2025-11-011
PRE
Powles, Thomas; Tagawa, Scott T.; Vulsteke, Christof; Gross-Goupil, Marine; Park, Se Hoon; Necchi, Andrea; De Santis, Maria; Duran, Ignacio; Morales-Barrera, Rafael; Guo, Jun; Sternberg, Cora N.; Bellmunt, Joaquim; Goebell, Peter J.; Kovalenko, Maria; Boateng, Freda; Sierecki, Mitch; Wang, Lu; Sima, Camelia S.; Waldes, Jana; Bangs, Rick; Loriot, Yohann; Grivas, Petros
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study

接受恩沃利单抗维多汀治疗的晚期尿路上皮癌患者中的治疗相关不良事件及关联结局：UNITE研究的分析

CANCER MEDICINE
IF3.1
2025-10-020
OAAI
Nizam, Amanda; Nguyen, Charles B.; Li, Jinju; Zabor, Emily C.; Msaouel, Pavlos; Jiang, Cindy Y.; Alhalabi, Omar; Oh, Eugene; Davidsohn, Matthew P.; Epstein, Ilana B.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Jindal, Tanya; Taylor, Amy K.; Glover, Michael J.; Khaki, Ali Raza; Lemke, Emily; Mabey, Hannah; Abuqayas, Bashar; Jang, Albert; Brown, Jason R.; Evans, Sean T.; Pywell, Cameron; Basu, Arnab; Bilen, Mehmet A.; Barata, Pedro C.; Zakharia, Yousef; Milowsky, Matthew I.; Kilari, Deepak; Hoimes, Christopher J.; Shah, Sumit A.; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Campbell, Matthew T.; Alva, Ajjai S.; Koshkin, Vadim S.
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study

恩福妥单抗（Enfortumab Vedotin）在具有不同组织学亚型的晚期尿路上皮癌患者中的疗效：UNITE研究的分析

European Urology
IF25.2
2025-09-140
PRE
Tanya Jindal; Cindy Y. Jiang; Omar Alhalabi; Charles B. Nguyen; Eugene Oh; Irene Tsung; Dimitra Rafailia Bakaloudi; Rafee Talukder; Matthew Davidsohn; Dory Freeman; Ilana Y. Epstein; Chien-Kuang Cornelia Ding; Amanda Nizam; Michael J. Glover; Ali Raza Khaki; Amy K. Taylor; Emily Lemke; Albert Jang; Sean T. Evans; Denny Shin; Cameron Pywell; Arnab Basu; Mehmet A. Bilen; Yousef Zakharia; Pedro Barata; Matthew I. Milowsky; Jason Brown; Deepak Kilari; Hamid Emamekhoo; Christopher J. Hoimes; Sumit Shah; Nancy B. Davis; Shilpa Gupta; Petros Grivas; Joaquim Bellmunt; Ajjai Alva; Matthew T. Campbell; Vadim S. Koshkin
A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy

TROPHY-U-01研究（队列2）的通俗总结：在无法接受顺铂为基础化疗的转移性尿路上皮癌患者中，免疫疗法后使用sacituzumab govitecan的疗效。

FUTURE ONCOLOGY
IF2.6
2025-09-010
OAAI
Grivas, Petros; Tagawa, Gurdeep; Jain, Rohit K.; Bupathi, Manojkumar; Balar, Arjun; Rezazadeh Kalebasty, Arash; George, Saby; Palmbos, Phillip; Nordquist, Luke; Petrylak, Daniel P.; Davis, Nancy; Sternberg, Cora N.; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Zhou, Huafeng; Bangs, Rick; Loriot, Yohann
Early real-world utilization of avelumab switch maintenance among patients with advanced urothelial carcinoma without progression following treatment with first-line platinum-based chemotherapy

在经过一线铂类化疗后未出现进展的晚期尿路上皮癌患者中，avelumab转换维持治疗的早期真实世界应用。

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
2025-09-010
OAAI
Moon, Helen H.; Aragon-Ching, Jeanny B.; Thompson, Allison; Abraham, Anup; Vlahiotis, Anna; Ike, Chiemeka; Benjumea, Darrin; Shao, Anran; Sun, Haiyan; Kearney, Mairead; Gharibian, Norbek; Hanson, Sarah; Li, Benjamin; Kirker, Melissa; Grivas, Petros
HER2 and urothelial carcinoma: current understanding and future directions

HER2与尿路上皮癌：当前认知与未来方向

Nature Reviews Urology
IF14.6
2025-08-150
PRE
Daniele Raggi; Emanuele Crupi; Filippo Pederzoli; Alberto Martini; Alberto Briganti; Omar Alhalabi; Peter H. O’Donnell; Jeffrey Ross; Shilpa Gupta; Ashish M. Kamat; Bishoy M. Faltas; Peter C. Black; Phillip E. Spiess; Petros Grivas; Jianjun Gao; Andrea B. Apolo; Robert A. Huddart; Andrea Necchi; Matthew D. Galsky

研究方向

暂未获取到该数据
J
Joaquim Bellmunt
H 指数:106论文数:1,140被引数:6.6万
A
Andrea Necchi
H 指数:70论文数:1,307被引数:3.2万
Y
Yohann Loriot
H 指数:76论文数:1,129被引数:5.3万
S
Shilpa Gupta
H 指数:49论文数:557被引数:1.5万
T
Thomas Powles
H 指数:77论文数:690被引数:3.6万
S
Srikala S. Sridhar
H 指数:50论文数:520被引数:1.5万
V
Vadim S. Koshkin
H 指数:29论文数:280被引数:5,202
M
Matthew D. Galsky
H 指数:79论文数:852被引数:3.4万
D
Daniel P. Petrylak
H 指数:87论文数:829被引数:4.5万
G
Guru Sonpavde
H 指数:77论文数:1,117被引数:2.7万